Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL23149170

FC(F)(F)c1ccc(COC2CNC2)nc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LPL P06858 2/20 0.46
LIPC P11150 2/20 0.46
LIPG Q9Y5X9 2/20 0.46
SLC6A4 P31645 3/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40
KMT2A Q03164 1/20 0.40
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
KDM1A O60341 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.37
DAO P14920 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
SCN9A Q15858 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL29616758 1.00 LPL (0.46) LPLLIPCLIPGSLC6A4HTR2C
SCHEMBL21618376 0.91 SLC6A4 (0.42) LPLLIPCLIPGSLC6A4HTR2C
Trifluoroacetic Acid SCHEMBL30945211 0.76 IDO1 (0.47) LPLLIPCLIPGSLC6A4HTR2C
Trifluoroacetic Acid SCHEMBL23152297 0.76 IDO1 (0.47) LIPGSLC6A4HTR2CHTR2BDAO
Trifluoroacetic Acid SCHEMBL25325427 0.75 SLC6A4 (0.45) SLC6A4HTR2CHTR2BKMT2APPARD
Trifluoroacetic Acid SCHEMBL23150549 0.75 MGLL (0.49) SLC6A4HTR2CHTR2BMRGPRX4DAO
Trifluoroacetic Acid SCHEMBL22462993 0.74 CHRNA7 (0.48) MRGPRX4SCN9A
Trifluoroacetic Acid SCHEMBL31411020 0.73 ALOX5AP (0.36)
Trifluoroacetic Acid SCHEMBL26620566 0.72 LIPG (0.49) LIPGSCN9A
Hydrochloric Acid SCHEMBL21640519 0.70 KDM1A (0.44) HTR2CKMT2AKDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4034538-A1 NEW HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. Hoffmann-La Roche AG (CH) 2022-08-03 EP disclosed
WO-2021058445-A1 NEW HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2021-04-01 WO disclosed
US-20210094973-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2021-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210094973-A1 HETEROCYCLIC COMPOUNDS H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP1A1, CYP1B1 LPL 4463/4885LIPC 2589/4885LIPG 4628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.